EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression

Shuyun Jiang, Hongwei Ma, Zhanwei Du, Zhijun Ma, Xiaowu Wang

Frontiers in Oncology · 09.06.2026 · 16

DOI: 10.3389/fonc.2026.1813451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 09.06.2026. Verfasst von Shuyun Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine, Qinghai University, Xining, Qinghai, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer is the most common malignant tumor worldwide, and its high heterogeneity limits the efficacy of current clinical therapies. R-spondin 2 (RSPO2) expression is closely associated with breast cancer subtypes, but the precise mechanisms by which it drives disease progression, particularly its relationship with ferroptosis, remain unclear.

Methods

RSPO2 expression was examined in primary breast cancer specimens and in MCF-7 and MDA-MB-231 cell lines. Functional assays, including proliferation, migration, and invasion tests, were performed following RSPO2 overexpression. In vivo tumor growth was assessed using a xenograft mouse model. Mechanistically, immunoprecipitation, ubiquitination assays, RNA sequencing (RNA-seq), RIP-qPCR, mRNA stability assays, and ferroptosis-related measurements (ROS, GSH, MDA, Fe 2+ ) were employed to identify interacting proteins and downstream targets. Rescue experiments with FSP1 overexpression were conducted to validate pathway specificity.

Results

RSPO2 was consistently downregulated in malignant breast cancer tissues. Restoring RSPO2 expression markedly suppressed cell proliferation, migration, and invasion in vitro and inhibited tumor growth in vivo. Mechanistically, RSPO2 recruited the E3 ubiquitin ligase TRIM21 to promote PTBP1 ubiquitination and proteasomal degradation. RNA-seq and validation assays revealed that PTBP1 bound the 3′UTR of ferroptosis suppressor protein 1 (FSP1) mRNA, enhancing its stability. RSPO2 overexpression reduced PTBP1 levels, leading to decreased FSP1 mRNA stability and expression. Consequently, RSPO2 overexpression triggered ferroptosis, as evidenced by ROS accumulation, GSH depletion, and elevated MDA and Fe 2+ levels. These effects were effectively reversed by FSP1 overexpression, which also abrogated the RSPO2 induced inhibition of cell proliferation, migration, and invasion.

Discussion

This study demonstrates that RSPO2 functions as a tumor suppressor in breast cancer by recruiting TRIM21 to degrade PTBP1, thereby reducing FSP1 mRNA stability and promoting ferroptosis. The RSPO2/PTBP1/FSP1 signaling axis is identified for the first time in breast cancer and represents a promising novel therapeutic target.

Schlagwörter

Stichwörter der Autor:innen

FSP1PTBP1RSPO2breast cancerferroptosis

Autor:innen und Institutionen

  • College of Clinical Medicine, Qinghai University, Xining, Qinghai, China.
  • Department of Surgical Oncology, The Affiliated Hospital of Qinghai University, Xining, Qinghai, China.

Zitieren

APA

Jiang, S., Ma, H., Du, Z., Ma, Z., & Wang, X. (2026). RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1813451

Vancouver

Jiang S, Ma H, Du Z, Ma Z, Wang X. RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1813451

BibTeX
@article{Jiang2026,
  author = {Jiang, Shuyun and Ma, Hongwei and Du, Zhanwei and Ma, Zhijun and Wang, Xiaowu},
  title = {RSPO2-induced ferroptosis via PTBP1-mediated FSP1 mRNA decay suppresses breast cancer progression},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1813451}
}
Kostenlos starten →